share_log

Novavax | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(4.32%)

ノババックス | SC 13G/A:大量保有報告書(訂正)-STATE STREET CORPORATION(4.32%)

SEC announcement ·  07/10 06:19
Moomoo AIのまとめ
State Street Corporation, a financial services and bank holding company headquartered in Boston, Massachusetts, has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on June 30, 2024, indicating a change in its holdings of Novavax Inc. common stock. According to the filing, State Street Corporation now has shared voting power over 5,597,236 shares and shared dispositive power over 6,066,179 shares of Novavax Inc. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of Novavax's class of common stock. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose or effect of changing or...Show More
State Street Corporation, a financial services and bank holding company headquartered in Boston, Massachusetts, has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on June 30, 2024, indicating a change in its holdings of Novavax Inc. common stock. According to the filing, State Street Corporation now has shared voting power over 5,597,236 shares and shared dispositive power over 6,066,179 shares of Novavax Inc. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of Novavax's class of common stock. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose or effect of changing or influencing the control of Novavax, nor in connection with any transaction having such purpose or effect. The subsidiaries of State Street Corporation listed in the filing, all classified as investment advisors (IA), include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, State Street Global Advisors Trust Company, and State Street Global Advisors, Australia, Limited.
フィナンシャルサービスおよび銀行持株会社であるState Street Corporationは、マサチューセッツ州ボストンに本社を置いており、2024年6月30日に米国証券取引委員会(SEC)に修正されたスケジュール13Gを提出し、Novavax Inc.普通株式の保有状況に変更があったことを示唆しています。報告書によると、State Street Corporationは現在、Novavax Inc.の5,597,236株の共有投票権と、6,066,179株の共有議決権を持っています。これは、State Street Corporationによって有利に所有される株式合計がNovavaxの...すべて展開
フィナンシャルサービスおよび銀行持株会社であるState Street Corporationは、マサチューセッツ州ボストンに本社を置いており、2024年6月30日に米国証券取引委員会(SEC)に修正されたスケジュール13Gを提出し、Novavax Inc.普通株式の保有状況に変更があったことを示唆しています。報告書によると、State Street Corporationは現在、Novavax Inc.の5,597,236株の共有投票権と、6,066,179株の共有議決権を持っています。これは、State Street Corporationによって有利に所有される株式合計がNovavaxの普通株式の5%以上を占めるため、同社にとって重要な株式保有であることを示しています。報告書によると、これらの株式は、Novavaxの支配権を変更または影響する目的や効果を持つ取引と関連しているわけではなく、通常業務において取得されたものです。報告書には、投資顧問(IA)と分類されるState Street Corporationの子会社であるSSGA Funds Management, Inc.、State Street Global Advisors Europe Limited、State Street Global Advisors Limited、State Street Global Advisors Trust Company、およびState Street Global Advisors, Australia, Limitedがリストされています。
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報